Desmopressin

This classification denotes an antidiurectic hormone analogue with the molecular formula C46H64N14O12S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ENR1LLB0FP, chemically known as vasopressin, 1-(3-mercaptopropanoic acid)-8-d-arginine- but generally known as desmopressin, which bears US NIH Compound Identifier 27991. European Medicines Agency schedules Desmopressin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07001MIG. The term DESMOPRESSIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules desmopressin in its Anatomical Therapeutic Chemical (ATC) Classification. DESMOPRESSIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule desmopressin under HS 29371900 and SITC 54154. As of Q4 2014, DESMOPRESSIN remains the US FDA Preferred Term for this commodity. Desmopressin bears US NLM identifiers UMLS ID C0011701 and NCI Concept Code C61701. SMILES: S1SCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C(CCC2)C(=O)NC(CCC/N=C(/N)N)C(=O)NCC(=O)N)C1)CC(=O)N)CCC(=O)N)CC1CCCCC1)CC1CCC(O)CC1.